Does CERTOLIZUMAB PEGOL Cause Therapy cessation? 390 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 390 reports of Therapy cessation have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.4% of all adverse event reports for CERTOLIZUMAB PEGOL.
390
Reports of Therapy cessation with CERTOLIZUMAB PEGOL
0.4%
of all CERTOLIZUMAB PEGOL reports
1
Deaths
64
Hospitalizations
How Dangerous Is Therapy cessation From CERTOLIZUMAB PEGOL?
Of the 390 reports, 1 (0.3%) resulted in death, 64 (16.4%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 390 reports have been filed with the FAERS database.
What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?
Drug ineffective (23,838)
Rheumatoid arthritis (17,782)
Pain (13,929)
Fatigue (11,438)
Off label use (10,281)
Rash (9,663)
Alopecia (9,111)
Maternal exposure during pregnancy (9,013)
Arthralgia (8,993)
Abdominal discomfort (8,615)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which CERTOLIZUMAB PEGOL Alternatives Have Lower Therapy cessation Risk?
CERTOLIZUMAB PEGOL vs CERTOPARIN
CERTOLIZUMAB PEGOL vs CETIRIZINE
CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB PEGOL vs CETRIMIDE
CERTOLIZUMAB PEGOL vs CETRORELIX